tiprankstipranks
Trending News
More News >
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (HK:1858)
:1858
Hong Kong Market
Advertisement

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) Ratios

Compare
1 Followers

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Ratios

HK:1858's free cash flow for Q2 2025 was ¥0.57. For the 2025 fiscal year, HK:1858's free cash flow was decreased by ¥ and operating cash flow was ¥0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.89 4.44 4.66 5.57 3.41
Quick Ratio
4.73 3.80 4.23 5.20 2.95
Cash Ratio
2.34 1.87 1.61 3.95 1.88
Solvency Ratio
0.34 0.41 0.49 0.64 0.65
Operating Cash Flow Ratio
-2.44 0.76 0.07 0.37 0.71
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 2.27B¥ 2.24B¥ 2.09B¥ 1.92B¥ 791.79M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.20 1.27 1.25 1.21 1.43
Debt Service Coverage Ratio
5.38K 856.65 20.84 1.23K 2.14K
Interest Coverage Ratio
5.82K 838.61 20.29 1.43K 2.33K
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 0.05 <0.01 <0.01
Net Debt to EBITDA
-6.37 -3.71 -2.60 -4.81 -1.97
Profitability Margins
Gross Profit Margin
60.22%72.48%76.03%77.11%72.60%
EBIT Margin
15.54%25.32%28.04%34.76%35.71%
EBITDA Margin
19.49%28.19%30.54%32.58%37.30%
Operating Profit Margin
19.24%25.32%27.37%33.17%35.20%
Pretax Profit Margin
19.25%25.31%28.04%33.15%35.18%
Net Profit Margin
17.57%22.99%25.61%29.09%30.22%
Continuous Operations Profit Margin
17.54%22.99%25.61%29.09%30.22%
Net Income Per EBT
91.24%90.82%91.34%87.75%85.91%
EBT Per EBIT
100.06%99.98%102.42%99.94%99.92%
Return on Assets (ROA)
4.60%7.61%9.02%10.75%18.40%
Return on Equity (ROE)
5.63%9.66%11.31%13.06%26.25%
Return on Capital Employed (ROCE)
5.85%10.29%11.69%14.36%28.16%
Return on Invested Capital (ROIC)
5.33%9.34%10.67%12.59%24.17%
Return on Tangible Assets
4.77%7.94%9.41%11.24%19.70%
Earnings Yield
1.55%6.69%5.69%7.54%4.45%
Efficiency Ratios
Receivables Turnover
3.48 2.74 1.57 2.10 2.53
Payables Turnover
2.02 1.48 1.21 3.27 2.85
Inventory Turnover
0.65 0.77 1.11 1.59 1.52
Fixed Asset Turnover
1.94 2.60 2.58 2.81 5.76
Asset Turnover
0.26 0.33 0.35 0.37 0.61
Working Capital Turnover Ratio
0.39 0.54 0.57 0.77 1.24
Cash Conversion Cycle
489.61 362.73 260.98 291.89 255.71
Days of Sales Outstanding
104.97 133.41 233.10 173.84 144.44
Days of Inventory Outstanding
565.23 476.76 329.16 229.82 239.54
Days of Payables Outstanding
180.59 247.44 301.28 111.78 128.27
Operating Cycle
670.21 610.17 562.26 403.66 383.98
Cash Flow Ratios
Operating Cash Flow Per Share
-3.14 1.33 0.11 0.48 0.75
Free Cash Flow Per Share
-3.29 1.24 0.04 -0.10 0.68
CapEx Per Share
0.15 0.09 0.06 0.58 0.07
Free Cash Flow to Operating Cash Flow
1.05 0.94 0.39 -0.21 0.91
Dividend Paid and CapEx Coverage Ratio
-3.22 3.34 0.55 0.83 7.27
Capital Expenditure Coverage Ratio
-20.55 15.39 1.65 0.83 10.86
Operating Cash Flow Coverage Ratio
-4.67K 291.92 31.20 134.36 140.74
Operating Cash Flow to Sales Ratio
-1.29 0.42 0.03 0.15 0.28
Free Cash Flow Yield
-11.85%11.52%0.30%-0.81%3.72%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
65.62 14.95 17.57 13.26 22.47
Price-to-Sales (P/S) Ratio
11.63 3.44 4.50 3.86 6.79
Price-to-Book (P/B) Ratio
3.62 1.44 1.99 1.73 5.90
Price-to-Free Cash Flow (P/FCF) Ratio
-8.58 8.68 335.68 -123.44 26.90
Price-to-Operating Cash Flow Ratio
-8.92 8.12 131.82 25.94 24.42
Price-to-Earnings Growth (PEG) Ratio
2.79 -1.50 -1.26 0.99 1.09
Price-to-Fair Value
3.62 1.44 1.99 1.73 5.90
Enterprise Value Multiple
53.30 8.48 12.13 7.03 16.24
Enterprise Value
9.31B 2.89B 4.45B 2.54B 5.68B
EV to EBITDA
52.30 8.48 12.13 7.03 16.24
EV to Sales
10.20 2.39 3.70 2.29 6.06
EV to Free Cash Flow
-7.52 6.04 276.32 -73.32 23.99
EV to Operating Cash Flow
-7.89 5.65 108.51 15.41 21.78
Tangible Book Value Per Share
7.40 7.07 6.73 6.74 2.83
Shareholders’ Equity Per Share
7.73 7.46 7.09 7.12 3.12
Tax and Other Ratios
Effective Tax Rate
0.09 0.09 0.09 0.12 0.14
Revenue Per Share
2.43 3.13 3.13 3.20 2.71
Net Income Per Share
0.43 0.72 0.80 0.93 0.82
Tax Burden
0.91 0.91 0.91 0.88 0.86
Interest Burden
1.24 1.00 1.00 0.95 0.99
Research & Development to Revenue
0.13 0.13 0.14 0.09 0.08
SG&A to Revenue
0.06 <0.01 <0.01 <0.01 0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-7.36 1.84 0.13 0.51 0.92
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis